Quantitative MRI of Bone Marrow Fat Fraction in Patients With Trepanobiopsy
NCT ID: NCT04761965
Last Updated: 2023-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2021-02-16
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
NCT00004994
Landmark vs. Ultrasound-Assisted Bone Marrow Biopsy Procedure Study
NCT05258357
Evaluation, Treatment, and Training for Patients With Blood Disorders
NCT00001397
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
NCT05012111
Quality of Life in Young Patients Undergoing Bone Marrow Transplant
NCT06476691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
MRI may become a new non-invasive method for assessing the cellularity of the bone marrow in children with oncohematological diseases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bone marrow cellularity by mDixon-quant
if trepanobiopsy was performed during the diagnosis, then comparison with MRI Bone marrow cellularity by mDixon-quant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. aplastic anemia
2. chronic myeloproliferative disease
3. reactive changes in hematopoiesis
Exclusion Criteria
2. Presence of contraindications for MRI examination
3. Extremely serious condition of the patient at the time of inclusion in the study.
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology
Moscow, Samory-Mashela,1, Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCPHOI-2019-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.